PRAX: Praxis Precision Medicines, Inc. Stock

by  •  • Comments Off on PRAX: Praxis Precision Medicines, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 780.34
Enterprise Value ($M) 614.77
Book Value ($M) 439.21
Book Value / Share 21.56
Price / Book 1.78
NCAV ($M) 438.08
NCAV / Share 21.51
Price / NCAV 1.78

Profitability (mra)
Return on Invested Capital (ROIC) -0.48
Return on Assets (ROA) -0.85
Return on Equity (ROE) -0.93

Liquidity (mrq)
Quick Ratio 12.42
Current Ratio 12.42

Balance Sheet (mrq) ($M)
Current Assets 477.61
Assets 478.74
Liabilities 39.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 8.55
Operating Income -200.16
Net Income -182.82

Cash Flow Statement (mra) ($M)
Cash From Operations -131.76
Cash from Investing -248.49
Cash from Financing 514.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-19 13G Soleus Capital Master Fund, L.P. 5.00
02-14 13G/A Perceptive Advisors Llc 9.50 63.51
02-14 13G/A Point72 Asset Management, L.P. 6.30 -29.09
02-14 13G/A Cormorant Asset Management, LP 9.08 94.62
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 6.10 31.31
02-05 13G Morgan Stanley 6.20
11-14 13G Price T Rowe Associates Inc /md/ 6.30
11-14 13G/A Verition Fund Management LLC 1.80 -55.29
11-14 13G/A Ra Capital Management, L.p. 4.30 -38.33
11-12 13G Capital Research Global Investors 5.60
11-12 13G/A Adage Capital Management, L.P. 4.81
11-12 13G/A Vanguard Group Inc 5.85 0.00
11-08 13G BlackRock, Inc. 7.30 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 79,570 209,121 38.05
2025-05-08 92,379 264,167 34.97
2025-05-07 151,406 602,336 25.14
2025-05-06 98,191 411,764 23.85
2025-05-05 118,008 355,887 33.16

(click for more detail)

Similar Companies
PHVS – Pharvaris N.V. PLRX – Pliant Therapeutics, Inc.
PMVP – PMV Pharmaceuticals, Inc. PRLD – Prelude Therapeutics Incorporated
PRTA – Prothena Corporation plc


Financial data and stock pages provided by
Fintel.io